oalib
Search Results: 1 - 10 of 100 matches for " "
All listed articles are free for downloading (OA Articles)
Page 1 /100
Display every page Item
The different health care practices in the history of brazilian public health nursing
Luciana Valad?o Alves Kebian, Sonia Acioli
Revista de Enfermagem UFPE On Line , 2010,
Abstract: Objective: to recover the different health care practices performed throughout the history of public health nursing in Brazil, since the 20th century. Methodology: the research was conducted through literature review, in February 2010, the databases Scielo and Database of Nursing. Moreover, it was researched in the Library of the Faculty of Nursing, University of Rio de Janeiro. For the screening of the studies used the analysis of titles and abstracts. Results: it was observed that nursing care was founded care practices on religion and charity; and evolved from 20th century repressive health practices and strictly curative and individualizing biomedicine techniques to humanized and comprehensive practices, as proposed by the new nursing theories, and collective practices, as recommended by principles and guidelines of the Unique Health System. Conclusion: the individualizing and curative care practices used throughout nursing history still permeate nurses’ work. Although today a number of care practices are focused on collectivity, comprehensive care and health promotion, the hospital-centric approach remains strong, hence promoting stratified and palliative health care.
Depression during pregnancy in the Brazilian public health care system
Silva, Ricardo Azevedo da;Jansen, Karen;Souza, Luciano Dias de Mattos;Moraes, Inácia Gomes da Silva;Tomasi, Elaine;Silva, Giovanna Del Grande da;Dias, Michelle de Souza;Pinheiro, Ricardo Tavares;
Revista Brasileira de Psiquiatria , 2010, DOI: 10.1590/S1516-44462010000200008
Abstract: objective: to estimate the prevalence of depression and correlate clinical and demographic characteristics in pregnant women assisted by the public health system in the city of pelotas, rs, brazil. method: we performed a cross-sectional study focused on pregnant women assisted by the public health service. the edinburgh postnatal depression scale (epds) was used to screen for depression. results: in a sample of 1,264 pregnant women aged 12-46 years, 21.1% (n = 255) presented a depressive episode during pregnancy. the presence of depression was associated with older age, lower education, lack of a cohabiting partner, not being primiparous, planned pregnancy, abortion thoughts, psychological or psychiatric treatment, smoking and alcohol consumption during pregnancy, and stressful events. conclusion: pregnant women assisted by the brazilian public health system presented a high prevalence of depression. psychiatric history, lack of support, and stressful events increase the probability of antenatal depression.
Oral Care during Pregnancy: Attitudes of Brazilian Public Health Professionals  [PDF]
Renata Toledo Alves,Rosangela Almeida Ribeiro,Luciane Rezende Costa,Claudio Rodrigues Leles,Maria do Carmo Matias Freire,Saul Martins Paiva
International Journal of Environmental Research and Public Health , 2012, DOI: 10.3390/ijerph9103454
Abstract: There is little information about health professionals’ behavior regarding oral health care during pregnancy. We evaluated attitudes of obstetricians/gynecologists, nurses, and dentists working at a public community service towards pregnant women’s oral health. Health professionals responded to a self-applied questionnaire. Cluster analysis identified two clusters of respondents; Chi-square, Student’s t test, and logistic regression were used to compare the two clusters in terms of the independent variables. Respondents were categorized into cluster 1 ‘less favorable’ (n = 159) and cluster 2 ‘more favorable’ (n = 124) attitudes. Professionals that had attended a residency or specialization program (OR = 2.08, 95% CI = 1.15–3.77, p = 0.016) and worked exclusively at the public service (OR = 2.15, 95% CI = 1.10–4.20, p = 0.025) presented more favorable attitudes. Obstetricians/gynecologists (OR = 0.22, 95% CI = 0.09–0.54, p = 0.001) and nurses (OR = 0.50, 95% CI = 0.29–0.86, p = 0.013) showed less favorable attitudes than dentists. Health care providers’ attitudes regarding pregnant women’s oral health were related to their occupation, qualification, and dedication to the public service.
Lapatinib in patients with metastatic breast cancer following initial treatment with trastuzumab: an economic analysis from the Brazilian public health care perspective
Machado M, Einarson TR
Breast Cancer: Targets and Therapy , 2012, DOI: http://dx.doi.org/10.2147/BCTT.S37003
Abstract: patinib in patients with metastatic breast cancer following initial treatment with trastuzumab: an economic analysis from the Brazilian public health care perspective Original Research (973) Total Article Views Authors: Machado M, Einarson TR Published Date November 2012 Volume 2012:4 Pages 173 - 182 DOI: http://dx.doi.org/10.2147/BCTT.S37003 Received: 14 August 2012 Accepted: 04 October 2012 Published: 13 November 2012 Marcio Machado,1 Thomas R Einarson2 1GlaxoSmithKline Brasil Ltd, Rio de Janeiro, Brazil; 2Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Canada Objective: To evaluate, from the perspective of the Brazilian public health care system, the cost-effectiveness of lapatinib plus capecitabine (LAP/CAP) versus capecitabine alone (CAP) or trastuzumab plus capecitabine (TRAST/CAP) in the treatment of women with human epidermal growth factor receptor-2-positive metastatic breast cancer previously treated with trastuzumab. Methods: An economic model was developed to compare costs and clinical outcomes over a 5-year time horizon. Both costs and outcomes were discounted at a 5% rate, in accordance with Brazilian pharmacoeconomic guidelines. Clinical inputs were determined using indirect treatment comparisons. Costs were derived from public reimbursement databases and reported in 2010 Brazilian real (R$1 = USD$0.52). Clinical outcomes included progression-free survival years (PFYs), life-years (LYs) and quality-adjusted life-years (QALYs). The economic outcome was the incremental cost per LY, PFY, or QALY gained. The impact of variations in individual inputs (eg, drug cost, drug effectiveness) was examined using one-way sensitivity analyses. Overall model robustness was tested using probabilistic sensitivity analyses, varying the ranges of all input parameters within their standard distributions. Results: Expected cost per patient was R$41,195 for CAP, R$95,256 for LAP/CAP, and R$113,686 for TRAST/CAP. Respective LYs were 1.406, 1.695, and 1.465; PFYs were 0.473, 0.711, and 0.612; and QALYS were 0.769, 0.958, and 0.827. LAP/CAP dominated TRAST/CAP for all outcomes. Incremental cost-effectiveness ratios of LAP/CAP over CAP were R$186,563 for LYs, R$226,403 for PFYs, and R$284,864 for QALYs. Results remained unchanged in one-way sensitivity analyses. In probabilistic analyses, LAP/CAP was dominant over TRAST/CAP in 93.5% of simulations. Conclusion: LAP/CAP increases survival for women with human epidermal growth factor receptor-2-positive metastatic breast cancer. LAP/CAP is cost-effective against TRAST/CAP (ie, produces more benefits at a lower cost) and can be considered cost-effective over CAP at a willingness-to-pay of about R$290,000 (US$151,000) per QALY gained.
Lapatinib in patients with metastatic breast cancer following initial treatment with trastuzumab: an economic analysis from the Brazilian public health care perspective  [cached]
Machado M,Einarson TR
Breast Cancer: Targets and Therapy , 2012,
Abstract: Marcio Machado,1 Thomas R Einarson21GlaxoSmithKline Brasil Ltd, Rio de Janeiro, Brazil; 2Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, CanadaObjective: To evaluate, from the perspective of the Brazilian public health care system, the cost-effectiveness of lapatinib plus capecitabine (LAP/CAP) versus capecitabine alone (CAP) or trastuzumab plus capecitabine (TRAST/CAP) in the treatment of women with human epidermal growth factor receptor-2-positive metastatic breast cancer previously treated with trastuzumab.Methods: An economic model was developed to compare costs and clinical outcomes over a 5-year time horizon. Both costs and outcomes were discounted at a 5% rate, in accordance with Brazilian pharmacoeconomic guidelines. Clinical inputs were determined using indirect treatment comparisons. Costs were derived from public reimbursement databases and reported in 2010 Brazilian real (R$1 = USD$0.52). Clinical outcomes included progression-free survival years (PFYs), life-years (LYs) and quality-adjusted life-years (QALYs). The economic outcome was the incremental cost per LY, PFY, or QALY gained. The impact of variations in individual inputs (eg, drug cost, drug effectiveness) was examined using one-way sensitivity analyses. Overall model robustness was tested using probabilistic sensitivity analyses, varying the ranges of all input parameters within their standard distributions.Results: Expected cost per patient was R$41,195 for CAP, R$95,256 for LAP/CAP, and R$113,686 for TRAST/CAP. Respective LYs were 1.406, 1.695, and 1.465; PFYs were 0.473, 0.711, and 0.612; and QALYS were 0.769, 0.958, and 0.827. LAP/CAP dominated TRAST/CAP for all outcomes. Incremental cost-effectiveness ratios of LAP/CAP over CAP were R$186,563 for LYs, R$226,403 for PFYs, and R$284,864 for QALYs. Results remained unchanged in one-way sensitivity analyses. In probabilistic analyses, LAP/CAP was dominant over TRAST/CAP in 93.5% of simulations.Conclusion: LAP/CAP increases survival for women with human epidermal growth factor receptor-2-positive metastatic breast cancer. LAP/CAP is cost-effective against TRAST/CAP (ie, produces more benefits at a lower cost) and can be considered cost-effective over CAP at a willingness-to-pay of about R$290,000 (US$151,000) per QALY gained.Keywords: cost-effectiveness, metastatic breast cancer, lapatinib, trastuzumab, capecitabine
Swedish advanced home care: organizational structure and implications of adopting this care model in Brazilian health care system
Perroca, Marcia Galan;Ek, Anna-Christina;
Revista Latino-Americana de Enfermagem , 2004, DOI: 10.1590/S0104-11692004000600002
Abstract: the purpose of this paper was to describe the organization of the advanced home care program provided in a region of sweden and to discuss some benefits and implications of this model adoption in brazilian settings. data triangulation as interview, observation and questionnaire was used. thirty two professionals participated in this study. the organizational structure, working method, home visits, and related health resources were described. the investigated model presented both clear effectiveness and versatility; therefore feasible to be adopted in brazilian settings improving their population health care. doubtless, the improvement of life quality and security are the best benefits this model of care can provide.
Adapta o do aparelho de amplifica o sonora no SUS comparado com um modelo de adapta o compacto Hearing aid fitting at SUS (Brazilian Public Health Care System) compared with a compact fitting model  [cached]
Maria Cecília Bevilacqua,Orozimbo Alves Costa Filho,Eliane Aparecida Techi Castiquini,Ticiana Cristina de Freitas Zambonatto
Brazilian Journal of Otorhinolaryngology , 2013,
Abstract: Nos dias atuais é imprescindível identificar fatores que contribuem para a qualidade do atendimento audiológico prestado. O modelo de adapta o do AASI proposto pelo SUS implica no atendimento de multiprofissional para essa prática. Isto provoca alguns questionamentos necessários e atuais. OBJETIVO: Avaliar e comparar os resultados da adapta o do AASI do modelo de presta o de servi o proposto pelo SUS, com um modelo mais compacto e enxuto de atendimento. MéTODO: Foi realizado um estudo prospectivo longitudinal, com 174 participantes distribuídos aleatoriamente em: grupo SUS e grupo Streamline. Para ambos os grupos, foi aplicado o questionário International Outcome Inventory for Hearing Aids (IOI-HA), além da avalia o do índice de Reconhecimento de Fala (IRF) após 3 e 9 meses de adapta o. RESULTADOS: Os dois grupos tiveram a mesma melhora em rela o ao reconhecimento de fala após 9 meses de uso dos AASI e, no questionário IOI-HA, n o foi encontrada diferen a estatisticamente significante aos três e nove meses. CONCLUS O: As duas estratégias de atendimento n o tiveram diferen a do ponto de vista clínico, no que diz respeito aos resultados obtidos na avalia o dos pacientes quanto à adapta o dos AASI obtidos a curto e médio prazo, devendo ser consideradas modifica es no modelo atual de atendimento. In the present days it is critical to identify the factors that contribute to the quality of the audiologic care provided. The hearing aid fitting model proposed by the Brazilian Unified Health System (SUS) implies multidisciplinary care. This leads to some relevant and current questions. OBJECTIVE: To evaluate and compare the results of the hearing aid fitting model proposed by the SUS with a more compact and streamlined care. METHOD: We conducted a prospective longitudinal study with 174 participants randomly assigned to two groups: SUS Group and Streamline Group. For both groups we assessed key areas related to hearing aid fitting through the International Outcome Inventory for Hearing Aids (IOI-HA) questionnaire, in addition to evaluating the results of Speech Recognition Index (SRI) 3 and 9 months after fitting. RESULTS: Both groups had the same improvement related to the speech recognition after nine months of AASI use, and the IOI-HA didn't show any statically significant difference on three and nine months. CONCLUSION: The two strategies of care did not differ, from the clinical point of view, as regards the hearing aid fitting results obtained upon the evaluation of patients in the short and medium term, thus changes in the current model of care s
The Brazilian health system: highlighting the primary health care reform
Luis Fernando Rolim Sampaio
Italian Journal of Public Health , 2010, DOI: 10.2427/5693
Abstract: This paper aims to describe the health system reform in Brazil, highlight the primary health care reform and the development of the Family Health Program, as well as explore future directions based on the current situation. The paper’s first section provides an overview of the Brazilian Health System and a brief historical perspective of the health system reform. It sets out the principles of the health system based on its legal framework and analyses how these principles have been implemented. At the end of the first section, an overview of financial issues is provided. The second section focuses on the primary care reform and the Family Health Program. It describes the program’s structural and innovative process characteristics. It further describes some of the outcomes and impacts already documented in the literature. Finally, the paper explores challenges to the health system and the program’s sustainability.
Clinical investigations for SUS, the Brazilian public health system
Paula, Ana Patrícia de;Giozza, Silvana Pereira;Pereira, Michelle Zanon;Boaventura, Patrícia Souza;Santos, Leonor Maria Pacheco;Sachetti, Camile Giaretta;Tamayo, César Omar Carranza;Kowalski, Clarissa Campos Guaragna;Elias, Flavia Tavares Silva;Serruya, Suzanne Jacob;Guimar?es, Reinaldo;
Sao Paulo Medical Journal , 2012, DOI: 10.1590/S1516-31802012000300008
Abstract: context and objective: scientific and technological development is crucial for advancing the brazilian health system and for promoting quality of life. the way in which the brazilian ministry of health has supported clinical research to provide autonomy, self-sufficiency, competitiveness and innovation for the healthcare industrial production complex, in accordance with the national policy on science, technology and innovation in healthcare, was analyzed. design and setting: descriptive investigation, based on secondary data, conducted at the department of science and technology, ministry of health. methods: the ministry of health's research management database, pesquisasaúde, was analyzed from 2002 to 2009, using the key word "clinical research" in the fields "primary sub-agenda" or "secondary sub-agenda". the 368 projects retrieved were sorted into six categories: basic biomedical research, preclinical studies, expanded clinical research, clinical trials, infrastructure support and health technology assessment. from a structured review on "clinical research funding", results from selected countries are presented and discussed. results: the amount invested was r$ 140 million. the largest number of projects supported "basic biomedical research", while the highest amounts invested were in "clinical trials" and "infrastructure support". the southeastern region had the greatest proportion of projects and financial resources. in some respects, brazil is ahead of other brics countries (russia, india, china and south africa), especially with regard to establishing a national clinical research network. conclusion: the ministry of health ensured investments to encourage clinical research in brazil and contributed towards promoting cohesion between investigators, health policies and the healthcare industrial production complex.
Nursing care planning and the Brazilian Health System - an overview
Isabel CF da Cruz
Online Brazilian Journal of Nursing , 2008,
Abstract: The nursing care planning was not fully implemented in the Health System. The conference points out issues and strategies to be considered by nurses and managers.
Page 1 /100
Display every page Item


Home
Copyright © 2008-2017 Open Access Library. All rights reserved.